← Back to patent-cliff list
4-methylumbelliferyl trimebutine sulfate
Tier C — Watch / trade4-methylumbelliferyl trimebutine sulfate
Valenta Pharm Jsc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Opioid receptors, mAChRs
Indications (approved)：Cholecystitis, 胆囊运动障碍
Regional status
US
-
EU
Phase III
2025-12-12
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of 4-methylumbelliferyl trimebutine sulfate?
Approved indications include: Cholecystitis, 胆囊运动障碍.
When does the 4-methylumbelliferyl trimebutine sulfate patent expire?
No public expiry year is available for 4-methylumbelliferyl trimebutine sulfate yet; this page updates once verified.
How do I get a quote for 4-methylumbelliferyl trimebutine sulfate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29